Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.71 |
| ▸ | DNM1 | Q05193 | 10/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.56 |
| ▸ | RAD52 | P43351 | 2/20 | 0.56 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.52 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.52 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.50 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL29166554 | 1.00 | HTT (0.71) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| Phosphoric Acid SCHEMBL29166978 | 1.00 | HTT (0.71) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| Phosphoric Acid SCHEMBL28622942 | 1.00 | HTT (0.71) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| Phosphoric Acid SCHEMBL28635700 | 1.00 | HTT (0.71) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| Phosphoric Acid SCHEMBL29166546 | 1.00 | HTT (0.71) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| Phosphoric Acid SCHEMBL17529948 | 1.00 | HTT (0.71) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| Phosphoric Acid SCHEMBL28640480 | 1.00 | HTT (0.71) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| Didecyldimethylammonium SCHEMBL2311559 | 1.00 | HTT (0.71) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| Phosphoric Acid SCHEMBL29166854 | 1.00 | HTT (0.71) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| Phosphoric Acid SCHEMBL28623070 | 1.00 | HTT (0.71) | HTTDNM1KMT2AHSP90AA1RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2335687-B1 | USE OF MONOOLEIN AS A NEW AUXILIARY LIPID IN LIPOFECTION | UNIV DO MINHO (PT) | 2017-05-24 | — | — | EP | claimed |
| US-20110178164-A1 | APPLICATION ON MONOOLEIN AS A NEW HELPER LIPID IN TRANSFECTION | UNIVERSIDADE DO MINHO (PT) | 2011-07-21 | — | — | US | claimed |
| EP-2335687-A2 | USE OF MONOOLEIN AS A NEW AUXILIARY LIPID IN LIPOFECTION | Universidade do Minho (PT) | 2011-06-22 | — | — | EP | claimed |
| CN-119110847-A | Cyclic RNA vaccines against SARS-COV-2 variants and methods of use thereof | 北京大学 | 2024-12-10 | — | — | CN | disclosed |
| CN-104870022-B | In vivo production of proteins | 现代泰克斯公司 | 2024-11-12 | — | — | CN | disclosed |
| CN-118846026-A | Broad-spectrum influenza virus vaccine | 摩登纳特斯有限公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-118434756-A | Compositions and methods for ribonucleic acid Respiratory Syncytial Virus (RSV) vaccines | 达冕生物有限公司 | 2024-08-02 | — | — | CN | disclosed |
| CN-118414426-A | Single pot method for producing circular RNA | 北京大学 | 2024-07-30 | — | — | CN | disclosed |
| CN-118302181-A | Multigang TP53 and PAN-RAS mRNA cancer vaccine | 达冕生物有限公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-118119930-A | Compositions and methods for mRNA vaccines against novel coronavirus infection | 达冕生物有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-117795073-A | Constructs and methods for making circular RNAs | 北京大学 | 2024-03-29 | — | — | CN | disclosed |
| CN-112390871-A | In vivo production of proteins | 现代泰克斯公司 | 2021-02-23 | — | — | CN | disclosed |
| EP-2335687-B1 | USE OF MONOOLEIN AS A NEW AUXILIARY LIPID IN LIPOFECTION | UNIV DO MINHO (PT) | 2017-05-24 | — | — | EP | disclosed |
| US-20110178164-A1 | APPLICATION ON MONOOLEIN AS A NEW HELPER LIPID IN TRANSFECTION | UNIVERSIDADE DO MINHO (PT) | 2011-07-21 | — | — | US | disclosed |
| US-20110178164-A1 | APPLICATION ON MONOOLEIN AS A NEW HELPER LIPID IN TRANSFECTION | UNIVERSIDADE DO MINHO (PT) | 2011-07-21 | — | — | US | disclosed |
| EP-2335687-A2 | USE OF MONOOLEIN AS A NEW AUXILIARY LIPID IN LIPOFECTION | Universidade do Minho (PT) | 2011-06-22 | — | — | EP | disclosed |
| EP-2335687-A2 | USE OF MONOOLEIN AS A NEW AUXILIARY LIPID IN LIPOFECTION | Universidade do Minho (PT) | 2011-06-22 | — | — | EP | disclosed |
| WO-2010020935-A8 | APPLICATION ON MONOOLEIN AS A NEW HELPER LIPID IN TRANSFECTION | UNIVERSIDADE DO MINHO (PT) | 2011-03-31 | — | — | WO | disclosed |
| WO-2010020935-A3 | USE OF MONOOLEIN AS A NEW AUXILIARY LIPID IN LIPOFECTION | UNIVERSIDADE DO MINHO (PT) | 2010-06-17 | — | — | WO | disclosed |
| WO-2010020935-A2 | APPLICATION ON MONOOLEIN AS A NEW HELPER LIPID IN TRANSFECTION | UNIVERSIDADE DO MINHO (PT) | 2010-02-25 | — | — | WO | disclosed |